Skip to main content
. 2014 Sep;53(5):478–484.

Table 3.

Noncompartmental analysis of analgesic formulations

Tmax (h) Cmax (ng/mL) t1/2 (h) AUClast Tlast (h) AUCinf (hr*ng/mL) Cl/Fpred
Bup-SR 4 14.5 ng/mL 10.1 322 h×ng/mL 72 325 h×ng/mL 1.85 L/h/kg
Butp-SR 2 390 ng/mL not done 910 h×ng/mL 24 not done not done
Fent-SR 2 62.1 ng/mL 6.28 279 h×ng/mL 24 288 h×ng/mL 12.2 L/h/kg
Melox-SR 2 7370 ng/mL 6.96 44,200 h×ng/mL 72 44,300 h×ng/mL 0.136 L/h/kg
Melox 2 4740 ng/mL 3.08 12,500 h×ng/mL 12 12,900 h×ng/mL 0.077 L/h/kg
Carp-SR 4 149 µg/mL 10.2 1130 h×µg/mL 72 1140 h×µg/mL 13.2 mL/h/kg
Carp 2 52.5 µg/mL 6.88 399 h×µg/mL 24 434 h×µg/mL 11.5 mL/h/kg

Tmax, time of Cmax; Cmax, maximal concentration measured ; t1/2, terminal half-life; AUClast, AUC from time 0 to Tlast; Tlast, time point at which AUClast was calculated; AUCinf, AUC to infinity; Cl/Fpred, predicted clearance.